Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-κB pathway in mice

Free Radical Research

Volumn 46, Issue 1, 2012, Pages 50-60

  Giridharan, Vijayasree V ^a   Thandavarayan, Rajarajan A ^a   Bhilwade, Hari N ^b   Ko, Kam M ^c   Watanabe, Kenichi ^d   Konishi, Tetsuya ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^d NUPALS   (Japan)

Author keywords

Cisplatin; Comet assay; Genotoxicity; Micronucleus assay; Neurotoxicity; Schisandrin B

Indexed keywords

ACETYLCHOLINESTERASE; CASPASE 3; CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID PEROXIDASE; NITRITE; PROTEIN P53; SCHIZANDRIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR; BONE MARROW; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; ERYTHROPOIESIS; GENOTOXICITY; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; TASK PERFORMANCE;

ACETYLCHOLINESTERASE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; CASPASE 3; CISPLATIN; CYCLOOCTANES; DNA DAMAGE; DRUG INTERACTIONS; LIGNANS; MALE; MICE; MICE, INBRED BALB C; MOTOR SKILLS; MUTAGENICITY TESTS; NF-KAPPA B; OXIDATIVE STRESS; POLYCYCLIC COMPOUNDS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 83055169861     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.638291     Document Type: Article

References (53)

1. McKeage MJ. Comparative adverse effect profi les of platinum drugs. Drug Saf 1995;13:228-244.
2. Wozniak K, Czechowska A, Blasiak J. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571. Chem Biol Interact 2004;147:309-318. (Pubitemid 38591500)
3. Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncol 2000;9:29-39. (Pubitemid 30110388)
4. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-394.
5. Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicol 2006;27:992-1002. (Pubitemid 44838955)
6. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992;17:221-237. (Pubitemid 23207431)
7. Mendonca LM, Dos Santos GC, Antonucci GA, Dos Santos AC, Bianchi Mde L, Antunes LM. Evaluation of the cytotoxicity and genotoxicity of curcumin in PC12 cells. Mutat Res 2009;675:29-34.
8. Caceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK. Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study. Phytomed 1999;6:217-223. (Pubitemid 129633193)
9. Liu GT. Pharmacological actions and clinical use of fructus schizandrae. Chin Med J (Engl) 1989;102:740-749.
10. Xuejiang W, Magara T, Konishi T. Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats. Free Radic Res 1999;31:449-455. (Pubitemid 29531125)
11. Wang L, Nishida H, Ogawa Y, Konishi T. Prevention of oxidative injury in PC12 cells by a traditional Chinese medicine, Shengmai San, as a model of an antioxidant-based composite formula. Biol Pharm Bull 2003;26:1000-1004. (Pubitemid 41685427)
12. Ichikawa H, Wang L, Konishi T. Prevention of cerebral oxidative injury by post-ischemic intravenous administration of Shengmai San. Am J Chin Med 2006;34:591-600. (Pubitemid 44515279)
13. Ko KM, Chen N, Leung HY, Leong EP, Poon MK, Chiu PY. Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice. Biofactors 2008;34:331-342.
14. Song JX, Lin X, Wong RN, Sze SC, Tong Y, Shaw PC, Zhang YB. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res 2011;25:435-443.
15. G iridharan VV, Thandavarayan RA, Sato S, Ko KM, Konishi T. Prevention of scopolamine-induced memory defi cits by schisandrin B, an antioxidant lignan from Schisandra chinensis in mice. Free Radic Res 2011;45:950-958.
16. Ip SP, Poon MK, Wu SS, Che CT, Ng KH, Kong YC, Ko KM. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: protection against carbon tetrachloride toxicity. Planta Med 1995;61:398-401.
17. Chaubey RC, Bhilwade HN, Rajagopalan R, Bannur SV. Gamma ray induced DNA damage in human and mouse leucocytes measured by SCGE-Pro: a software developed for automated image analysis and data processing for Comet assay. Mutat Res 2001;490:187-197. (Pubitemid 32126686)
18. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-221. (Pubitemid 30196665)
19. Thandavarayan RA, Watanabe K, Sari FR, Ma M, Lakshmanan AP, Giridharan VV, et al. Modulation of doxorubicininduced cardiac dysfunction in dominant-negative p38alpha mitogen-activated protein kinase mice. Free Radic Biol Med 2010;49:1422-1431.
20. Schmid W. Chemical mutagen testing on in vivo somatic mammalian cells. Agents Actions 1973;3:77-85.
21. Bhilwade HN, Chaubey RC, Chauhan PS. Gamma ray induced bone marrow micronucleated erythrocytes in seven strains of mouse. Mutat Res 2004;560:19-26. (Pubitemid 38501737)
22. Narayan BH, Tatewaki N, Giridharan VV, Nishida H, Konishi T. Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice. Food Funct 2010;1:174-179.
23. Giridharan VV, Thandavarayan RA, Konishi T. Effect of Shengmai-san on Cognitive Performance and Cerebral Oxidative Damage in BALB/c Mice. J Med Food 2011;14:601-609.
24. Barros DM, Izquierdo LA, Mello e Souza T, Ardenghi PG, Pereira P, Medina JH, Izquierdo I. Molecular signalling pathways in the cerebral cortex are required for retrieval of one-trial avoidance learning in rats. Behav Brain Res 2000;114:183-192.
25. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-167. (Pubitemid 16239568)
26. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358. (Pubitemid 9194347)
27. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
28. Lankin VZ, Tikhaze AK, Kovalevskaia AL, Lemeshko VV, Vikhert AM. [Age-related changes in the glutathione-Stransferase and glutathione peroxidase activity of rat liver cytosol]. Dokl Akad Nauk SSSR 1981;261:1467-1470.
29. Ellman GL, Courtney KD, Andres V, Jr., Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
30. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fl uids. Anal Biochem 1982;126:131-138. (Pubitemid 13203451)
31. Song TY, Chen CL, Liao JW, Ou HC, Tsai MS. Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem Toxicol 2010;48:3492-3499.
32. F erreira IC, Barros L, Abreu RM. Antioxidants in wild mushrooms. Curr Med Chem 2009;16:1543-1560.
33. Zhong Y, Feng SL, Luo Y, Zhang GD, Kong ZM. Evaluating the genotoxicity of surface water of Yangzhong City using the Vicia faba micronucleus test and the comet assay. Bull Environ Contam Toxicol 2001;67:217-224. (Pubitemid 32661757)
34. Mazur L, Czyzewska A, Augustynek A. WR-2721: inhibitor of cisplatin-induced micronuclei. Teratog Carcinog Mutagen 2000;20:349-356.
35. Lin WC, Tsai PS, Huang CJ. Catecholamines' enhancement of inducible nitric oxide synthase-induced nitric oxide biosynthesis involves CAT-1 and CAT-2A. Anesth Analg 2005;101:226-232.
36. LeDoux JE. Emotional memory systems in the brain. Behav Brain Res 1993;58:69-79.
37. Novas ML, Wolfman C, Medina JH, de Robertis E. Proconvulsant and ' anxiogenic ' effects of n-butyl beta carboline-3-carboxylate, an endogenous benzodiazepine binding inhibitor from brain. Pharmacol Biochem Behav 1988;30:331-336. (Pubitemid 19264236)
38. Rodgers RJ, Cao BJ, Dalvi A, Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997;30:289-304. (Pubitemid 127521025)
39. Pardridge WM. Glucose transport and phosphorylation: which is rate limiting for brain glucose utilization? Ann Neurol 1994;35:511-512. (Pubitemid 24153833)
40. Hagrman D, Goodisman J, Dabrowiak JC, Souid AK. Kinetic study on the reaction of cisplatin with metallothionein. Drug Metab Dispos 2003;31:916-923. (Pubitemid 36759062)
41. Pong K. Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics. Expert Opin Biol Ther 2003;3:127-139. (Pubitemid 36193657)
42. Nabeshima T. Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory. Prog Brain Res 1993;98:405-411. (Pubitemid 23305673)
43. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NFkappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005;135: 2299-2304. (Pubitemid 41429581)
44. Rodriguez-Porcel M, Lerman LO, Holmes DR, Jr., Richardson D, Napoli C, Lerman A. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res 2002;53:1010-1018. (Pubitemid 34261039)
45. So H, Kim H, Lee JH, Park C, Kim Y, Kim E, et al. Cisplatin cytotoxicity of auditory cells requires secretions of proinfl ammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol 2007;8:338-355. (Pubitemid 47222431)
46. Li SF, Liu TF, Guo M, Wang ZP, Fan LH. [Effect of Schisandrin B on mitogen-activated protein kinases and nuclear factor-kappaB in rat lungs exposed to silica]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2010;28:329-333.
47. Wu H, Lozano G. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994;269:20067-20074.
48. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, Slack RS, Park DS. Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 2004;24:2963-2973. (Pubitemid 38405744)
49. Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2007;293:F1282-F1291. (Pubitemid 47583963)
50. Low WK, Kong SW, Tan MG. Ototoxicity from combined Cisplatin and radiation treatment: an in vitro study. Int J Otolaryngol 2010;2010:523976.
51. Brozovic G, Orsolic N, Knezevic F, Horvat Knezevic A, Benkovic V, Vrdoljak DV, Saric A. Evaluation of DNA damage in vivo induced by combined application of cisplatin and sevofl urane. Eur J Anaesthesiol 2008;25:642-647. (Pubitemid 351914996)
52. Park SA, Choi KS, Bang JH, Huh K, Kim SU. Cisplatininduced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatinmediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 2000;75:946-953. (Pubitemid 30660482)
53. Podratz JL, Staff NP, Froemel D, Wallner A, Wabnig F, Bieber AJ, et al. Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity. Neurobiol Dis 2011;43: 330-337.